Makes Brigid insider trades
Makes Brigid has filed 23 Form 4s with the SEC that we hold, for Vivani Medical, Inc. (VANI) (Chief Financial Officer), Elutia INC. (ELUT) (Director), Quantum-Si Inc (QSI) (Director) and Definium Therapeutics, Inc. (MNMD) (Director). Across all of them we count 8 purchases worth $35.2K and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($13.0K) and 0 sales ($0). The largest single trade was a purchase of 25,000 shares of Elutia INC. worth $13.0K, dated 2025-12-17. The first filing on our record is dated 2022-05-13 and the latest 2026-06-15.
Vivani Medical, Inc. (VANI)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-06-27 | P, purchase reported on Form 4 | 1,000 | $1.2K | 2023-06-29 |
| 2023-06-28 | P, purchase reported on Form 4 | 3,000 | $3.6K | 2023-06-29 |
| 2023-08-31 | P, purchase reported on Form 4 | 2,000 | $1.8K | 2023-09-05 |
| 2023-09-01 | P, purchase reported on Form 4 | 4,000 | $3.8K | 2023-09-05 |
| 2023-12-15 | P, purchase reported on Form 4 | 4,000 | $3.6K | 2023-12-18 |
| 2023-12-18 | P, purchase reported on Form 4 | 1,000 | $870 | 2023-12-18 |
Elutia INC. (ELUT)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-12-09 | P, purchase reported on Form 4 | 2,000 | $7.3K | 2022-12-12 |
| 2025-12-17 | P, purchase reported on Form 4 | 25,000 | $13.0K | 2025-12-18 |
Quantum-Si Inc (QSI)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Definium Therapeutics, Inc. (MNMD)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1375927) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms